These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2841880)

  • 41. Neutralizing antibody rather than cellular immune response is maintained for nearly 20 years among Japanese encephalitis SA14-14-2 vaccinees in an endemic setting.
    Wang R; Fan D; Wang L; Li Y; Zhou H; Gao N; An J
    Infect Genet Evol; 2020 Nov; 85():104476. PubMed ID: 32736041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of cytoxan on immune response of Japanese encephalitis virus killed and live vaccines].
    Fang QA; Chen BQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):317-21. PubMed ID: 2561510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trial of inactivated Japanese encephalitis vaccine in children with underlying diseases.
    Yamada A; Imanishi J; Juang RF; Fukunaga T; Okuno Y; Tadano M; Fukai K; Baba K; Yabuuchi H
    Vaccine; 1986 Mar; 4(1):32-4. PubMed ID: 3008460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines.
    Markoff L
    Vaccine; 2000 May; 18 Suppl 2():26-32. PubMed ID: 10821970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.
    Monath TP; Arroyo J; Levenbook I; Zhang ZX; Catalan J; Draper K; Guirakhoo F
    J Virol; 2002 Feb; 76(4):1932-43. PubMed ID: 11799188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
    [No Abstract]   [Full Text] [Related]  

  • 47. Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial.
    Feroldi E; Pancharoen C; Kosalaraksa P; Watanaveeradej V; Phirangkul K; Capeding MR; Boaz M; Gailhardou S; Bouckenooghe A
    Hum Vaccin Immunother; 2012 Jul; 8(7):929-37. PubMed ID: 22777096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of environment safety of a Japanese encephalitis live attenuated vaccine.
    Liu X; Jia L; Nie K; Zhao D; Na R; Xu H; Cheng G; Wang J; Yu Y; Li Y
    Biologicals; 2019 Jul; 60():36-41. PubMed ID: 31178277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea.
    Kim DS; Jang GC; Cha SH; Choi SH; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Bang J; Naimi Z; Bouckenooghe A; Bosch-Castells V; Houillon G
    Pediatr Infect Dis J; 2016 Feb; 35(2):e60-4. PubMed ID: 26535878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
    Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
    Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenicity of a single fractional intradermal dose of Japanese encephalitis live attenuated chimeric vaccine.
    Furuya-Kanamori L; Gyawali N; Mills DJ; Mills C; Hugo LE; Devine GJ; Lau CL
    J Travel Med; 2023 Apr; 30(2):. PubMed ID: 36308439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Field experiments on live attenuated Japanese encephalitis virus vaccine for swine.
    Ueba N; Kimura T; Nakajima S; Kurimura T; Kitaura T
    Biken J; 1978 Sep; 21(3):95-103. PubMed ID: 219844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children.
    Kwon HJ; Lee SY; Kim KH; Kim DS; Cha SH; Jo DS; Kang JH
    J Korean Med Sci; 2015 May; 30(5):612-6. PubMed ID: 25931793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults.
    Khan SA; Kakati S; Dutta P; Chowdhury P; Borah J; Topno R; Jadhav SM; Mohapatra PK; Mahanta J; Gupte MD
    Indian J Med Res; 2016 Dec; 144(6):886-892. PubMed ID: 28474625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects.
    Liu ZL; Hennessy S; Strom BL; Tsai TF; Wan CM; Tang SC; Xiang CF; Bilker WB; Pan XP; Yao YJ; Xu ZW; Halstead SB
    J Infect Dis; 1997 Nov; 176(5):1366-9. PubMed ID: 9359740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced cytopathic effect of Japanese encephalitis virus strain SA14-14-2: Probable association of mutation in amino acid of its envelope protein.
    Nath B; Gupta A; Khan SA; Kumar S
    Microb Pathog; 2017 Oct; 111():187-192. PubMed ID: 28867626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Japanese encephalitis immunization in South Korea: past, present, and future.
    Sohn YM
    Emerg Infect Dis; 2000; 6(1):17-24. PubMed ID: 10653564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.
    Capeding MR; Alberto ER; Bouckenooghe A; Laot TM; Chansinghakul D; Monfredo C; Machabert T; Feroldi E
    J Infect Dis; 2018 Jan; 217(4):567-571. PubMed ID: 29325161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand.
    Chotpitayasunondh T; Pruekprasert P; Puthanakit T; Pancharoen C; Tangsathapornpong A; Oberdorfer P; Kosalaraksa P; Prommalikit O; Tangkittithaworn S; Kerdpanich P; Techasaensiri C; Korejwo J; Chuenkitmongkol S; Houillon G
    Vaccine; 2017 Jan; 35(2):299-304. PubMed ID: 27903416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.